vs

Side-by-side financial comparison of GORMAN RUPP CO (GRC) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.

GORMAN RUPP CO is the larger business by last-quarter revenue ($166.6M vs $123.8M, roughly 1.3× NATURES SUNSHINE PRODUCTS INC). GORMAN RUPP CO runs the higher net margin — 8.3% vs 3.3%, a 4.9% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs 2.4%). GORMAN RUPP CO produced more free cash flow last quarter ($10.2M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 2.3%).

Gorman-Rupp is a pump manufacturer in Mansfield, Ohio. It manufactures pumps for municipal, water, wastewater, sewage, industrial, construction, petroleum, fire, and OEM markets. The company is traded on the New York Stock Exchange. Its current CEO is Scott King.

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.

GRC vs NATR — Head-to-Head

Bigger by revenue
GRC
GRC
1.3× larger
GRC
$166.6M
$123.8M
NATR
Growing faster (revenue YoY)
NATR
NATR
+2.4% gap
NATR
4.7%
2.4%
GRC
Higher net margin
GRC
GRC
4.9% more per $
GRC
8.3%
3.3%
NATR
More free cash flow
GRC
GRC
$2.6M more FCF
GRC
$10.2M
$7.6M
NATR
Faster 2-yr revenue CAGR
NATR
NATR
Annualised
NATR
5.6%
2.3%
GRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRC
GRC
NATR
NATR
Revenue
$166.6M
$123.8M
Net Profit
$13.7M
$4.1M
Gross Margin
31.4%
72.5%
Operating Margin
14.9%
4.3%
Net Margin
8.3%
3.3%
Revenue YoY
2.4%
4.7%
Net Profit YoY
25.2%
1379.4%
EPS (diluted)
$0.53
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRC
GRC
NATR
NATR
Q4 25
$166.6M
$123.8M
Q3 25
$172.8M
$128.3M
Q2 25
$179.0M
$114.8M
Q1 25
$163.9M
$113.2M
Q4 24
$162.7M
$118.2M
Q3 24
$168.2M
$114.6M
Q2 24
$169.5M
$110.6M
Q1 24
$159.3M
$111.0M
Net Profit
GRC
GRC
NATR
NATR
Q4 25
$13.7M
$4.1M
Q3 25
$11.3M
$5.3M
Q2 25
$15.8M
$5.3M
Q1 25
$12.1M
$4.7M
Q4 24
$11.0M
$-321.0K
Q3 24
$12.9M
$4.3M
Q2 24
$8.3M
$1.3M
Q1 24
$7.9M
$2.3M
Gross Margin
GRC
GRC
NATR
NATR
Q4 25
31.4%
72.5%
Q3 25
29.2%
73.3%
Q2 25
31.3%
71.7%
Q1 25
30.7%
72.1%
Q4 24
30.2%
72.0%
Q3 24
31.3%
71.3%
Q2 24
31.9%
71.4%
Q1 24
30.4%
71.2%
Operating Margin
GRC
GRC
NATR
NATR
Q4 25
14.9%
4.3%
Q3 25
12.4%
7.0%
Q2 25
15.0%
3.7%
Q1 25
13.5%
5.4%
Q4 24
13.0%
3.8%
Q3 24
14.2%
4.6%
Q2 24
15.4%
5.1%
Q1 24
12.8%
4.2%
Net Margin
GRC
GRC
NATR
NATR
Q4 25
8.3%
3.3%
Q3 25
6.6%
4.2%
Q2 25
8.8%
4.6%
Q1 25
7.4%
4.2%
Q4 24
6.7%
-0.3%
Q3 24
7.7%
3.8%
Q2 24
4.9%
1.2%
Q1 24
5.0%
2.1%
EPS (diluted)
GRC
GRC
NATR
NATR
Q4 25
$0.53
$0.23
Q3 25
$0.43
$0.30
Q2 25
$0.60
$0.28
Q1 25
$0.46
$0.25
Q4 24
$0.42
$-0.02
Q3 24
$0.49
$0.23
Q2 24
$0.32
$0.07
Q1 24
$0.30
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRC
GRC
NATR
NATR
Cash + ST InvestmentsLiquidity on hand
$35.1M
$93.9M
Total DebtLower is stronger
$307.5M
Stockholders' EquityBook value
$414.7M
$161.6M
Total Assets
$860.1M
$261.1M
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRC
GRC
NATR
NATR
Q4 25
$35.1M
$93.9M
Q3 25
$42.9M
$95.6M
Q2 25
$27.0M
$81.3M
Q1 25
$21.8M
$86.5M
Q4 24
$24.2M
$84.7M
Q3 24
$39.7M
$78.7M
Q2 24
$34.2M
$68.7M
Q1 24
$27.8M
$77.8M
Total Debt
GRC
GRC
NATR
NATR
Q4 25
$307.5M
Q3 25
$322.3M
Q2 25
$337.1M
Q1 25
$352.2M
Q4 24
$366.6M
Q3 24
$381.0M
Q2 24
$395.4M
Q1 24
$400.7M
$2.1M
Stockholders' Equity
GRC
GRC
NATR
NATR
Q4 25
$414.7M
$161.6M
Q3 25
$405.2M
$166.7M
Q2 25
$397.8M
$163.7M
Q1 25
$382.1M
$167.1M
Q4 24
$373.8M
$161.0M
Q3 24
$367.3M
$162.6M
Q2 24
$358.6M
$156.4M
Q1 24
$353.7M
$159.7M
Total Assets
GRC
GRC
NATR
NATR
Q4 25
$860.1M
$261.1M
Q3 25
$869.9M
$264.8M
Q2 25
$861.8M
$254.9M
Q1 25
$857.8M
$252.7M
Q4 24
$858.5M
$240.9M
Q3 24
$883.5M
$245.3M
Q2 24
$891.1M
$235.8M
Q1 24
$887.4M
$247.3M
Debt / Equity
GRC
GRC
NATR
NATR
Q4 25
0.74×
Q3 25
0.80×
Q2 25
0.85×
Q1 25
0.92×
Q4 24
0.98×
Q3 24
1.04×
Q2 24
1.10×
Q1 24
1.13×
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRC
GRC
NATR
NATR
Operating Cash FlowLast quarter
$15.0M
$9.9M
Free Cash FlowOCF − Capex
$10.2M
$7.6M
FCF MarginFCF / Revenue
6.1%
6.1%
Capex IntensityCapex / Revenue
2.9%
1.9%
Cash ConversionOCF / Net Profit
1.09×
2.41×
TTM Free Cash FlowTrailing 4 quarters
$88.9M
$28.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRC
GRC
NATR
NATR
Q4 25
$15.0M
$9.9M
Q3 25
$42.3M
$18.5M
Q2 25
$27.8M
$4.3M
Q1 25
$21.1M
$2.6M
Q4 24
$9.3M
$12.2M
Q3 24
$27.2M
$9.6M
Q2 24
$22.7M
$1.3M
Q1 24
$10.7M
$2.2M
Free Cash Flow
GRC
GRC
NATR
NATR
Q4 25
$10.2M
$7.6M
Q3 25
$35.8M
$16.8M
Q2 25
$24.8M
$3.0M
Q1 25
$18.1M
$1.5M
Q4 24
$5.2M
$10.0M
Q3 24
$24.0M
$7.9M
Q2 24
$19.4M
$-2.0M
Q1 24
$6.8M
$-1.5M
FCF Margin
GRC
GRC
NATR
NATR
Q4 25
6.1%
6.1%
Q3 25
20.7%
13.1%
Q2 25
13.9%
2.6%
Q1 25
11.0%
1.3%
Q4 24
3.2%
8.5%
Q3 24
14.3%
6.9%
Q2 24
11.5%
-1.9%
Q1 24
4.3%
-1.4%
Capex Intensity
GRC
GRC
NATR
NATR
Q4 25
2.9%
1.9%
Q3 25
3.8%
1.3%
Q2 25
1.7%
1.2%
Q1 25
1.8%
1.0%
Q4 24
2.5%
1.9%
Q3 24
1.9%
1.5%
Q2 24
1.9%
3.0%
Q1 24
2.5%
3.3%
Cash Conversion
GRC
GRC
NATR
NATR
Q4 25
1.09×
2.41×
Q3 25
3.73×
3.46×
Q2 25
1.76×
0.81×
Q1 25
1.74×
0.55×
Q4 24
0.84×
Q3 24
2.10×
2.21×
Q2 24
2.72×
0.97×
Q1 24
1.36×
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRC
GRC

Industrial$34.7M21%
Fire Market$31.4M19%
Municipal$25.3M15%
Agriculture$22.5M14%
Repair Parts$18.9M11%
Construction$17.3M10%
Original Equipment Manufacturer$10.8M7%
Petroleum$5.6M3%

NATR
NATR

Other$68.1M55%
General Health Products$20.2M16%
Digestive Products$13.8M11%
Cardiovascular Products$12.1M10%
Personal Care Products$4.4M4%
Immunity Products$3.1M3%
Weight Management Products$2.1M2%

Related Comparisons